Fucoidan mitigates gastric ulcer injury through managing inflammation, oxidative stress, and NLRP3-mediated pyroptosis
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110335 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Hend Mostafa Selim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt. Hauptthemen laut MEDLINE: Stomach Ulcer. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Washington State University.
Abstract (Originalsprache)
This study aimed to elucidate the gastro-protective effect of fucoidan against ethanol-induced gastric ulcer mediated via NLRP3-induced pyroptosis as an underlying mechanism, not yet assessed in prior research. Forty-eight male Albino mice were divided into six groups: Group I (normal control), group II (Ulcer/ethanol control), group III (Omeprazole + ethanol), group IV (fucoidan 25 mg + ethanol), group V (fucoidan 50 mg + ethanol) and group VI (fucoidan only). Fucoidan was administered orally for seven consecutive days followed by ulcer induction by a single oral dose of ethanol. Using colorimetric analysis, ELISA, qRT-PCR, histological assessment, and immunohistochemical studies, the results revealed that ethanol-induced ulcer exhibited an ulcer score of 42.5 ± 5.1 and a significant increase (p < 0.05) in malondialdehyde (MDA), nuclear factor kappa B (NF-κB), and interleukin 6 (IL-6) with a significant decrease in the gastro-protective mediators, prostaglandin E2 (PGE2), superoxide dismutase (SOD) and glutathione (GSH), accompanied with an increase in NLRP3, interleukin 1β (IL-1β), interleukin 18 (IL-18), caspase 1, caspase 11, gasdermin D, and toll-like receptor 4 (TLR4), compared with the normal control. Pre-treatment with fucoidan showed a comparable result with omeprazole. Additionally, pre-treatments elevated the levels of the gastro-protective mediators and lessened oxidative stress, relative to the positive control findings. Conclusively, fucoidan has a promising gastro-protective role by inhibiting inflammation and pyroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Department, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
- Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 4545, Saudi Arabia.
- Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt.
- Pharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
- Institute of Bioprocess Engineering, Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau, Gottlieb-Daimler-Straße 49, 67663 Kaiserslautern, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
- Washington State University
Zitieren
APA
Selim, H. M., Negm, W. A., Hawwal, M. F., Hussein, I. A., Elekhnawy, E., Ulber, R., & Zayed, A. (2023). Fucoidan mitigates gastric ulcer injury through managing inflammation, oxidative stress, and NLRP3-mediated pyroptosis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110335
Vancouver
Selim HM, Negm WA, Hawwal MF, Hussein IA, Elekhnawy E, Ulber R, et al. Fucoidan mitigates gastric ulcer injury through managing inflammation, oxidative stress, and NLRP3-mediated pyroptosis. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110335
BibTeX
@article{Selim2023,
author = {Selim, Hend Mostafa and Negm, Walaa A and Hawwal, Mohammed F and Hussein, Ismail A and Elekhnawy, Engy and Ulber, Roland and Zayed, Ahmed},
title = {Fucoidan mitigates gastric ulcer injury through managing inflammation, oxidative stress, and NLRP3-mediated pyroptosis},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110335}
}
EUVIMED